# Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

> **NCT00459901** · PHASE2 · TERMINATED · sponsor: **Peter Kozuch** · enrollment: 13 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Erlotinib and capecitabine

## Key facts

- **NCT ID:** NCT00459901
- **Lead sponsor:** Peter Kozuch
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Study halted by drug manufacturer
- **Last updated:** 2015-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459901, "Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00459901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*